Long-term outcomes and circulating tumor DNA analysis from a phase I/II study of lenalidomide and obinutuzumab with CHOP for newly diagnosed diffuse large B-cell lymphoma.

Hua-Jay Jeffery  Cherng

No Relationships to Disclose

Stefan  Alig

No Relationships to Disclose

Yasuhiro  Oki

Employment - Genentech; Jazz Pharmaceuticals (I)

Loretta J.  Nastoupil

Honoraria - ADC Therapeutics; Bayer; Bristol-Myers Squibb; Celgene; Epizyme; Genmab; Gilead Sciences; Janssen Oncology; Morphosys; Novartis; Pfizer; Takeda; TG Therapeutics

Research Funding - Allogene Therapeutics; Caribou Biosciences; Celgene; Epizyme; Genentech/Roche; Gilead Sciences; IgM Biosciences; Janssen Biotech; Novartis; Takeda; TG Therapeutics

Luis  Fayad

Consulting or Advisory Role - EUSA Pharma; medicamenta ecuatoriana; Roche

Sattva Swarup  Neelapu

Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences

Consulting or Advisory Role - Adicet Bio; Alimera Sciences; Athenex; Bluebird Bio; Bristol-Myers Squibb; Calibr; Gilead Sciences; Incyte; Kite, a Gilead company; Merck Sharp & Dohme; Novartis; Sana Biotechnology; Sellas Life Sciences

Research Funding - Adicet Bio; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Kite, a Gilead company; poseida therapeutics; Precision Biosciences; Unum Therapeutics

Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy; Royalty income from Takeda Pharmaceuticals

Francesco  Turturro

No Relationships to Disclose

Frederick B.  Hagemeister

No Relationships to Disclose

Maria Alma  Rodriguez

No Relationships to Disclose

Hun Ju  Lee

Honoraria - Aptitude Health; Cancer Experts Now; Century Therapeutics; Curio Science

Consulting or Advisory Role - BMS; Guidepoint Global

Research Funding - BMS; Celgene; Celgene; Oncternal Therapeutics; Seagen; Takeda

Timothy  McDonnell

No Relationships to Disclose

Christopher  Flowers

Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Celgene; Denovo Biopharma; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Spectrum Pharmaceuticals

Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Alimera Sciences (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millennium (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst); Xencor (Inst)

Francisco  Vega

Honoraria - i3 Health

Research Funding - crispr therapeutics; Geron

Michael Richard  Green

Stock and Other Ownership Interests  - KDAc Therapeutics

Honoraria - Daiichi Sankyo; Monte Rosa Therapeutics; Tessa Therapeutics

Research Funding - Abbvie; Allogene Therapeutics; Kite/Gilead; Sanofi

Ash A.  Alizadeh

Leadership - Lymphoma Research Foundation

Stock and Other Ownership Interests  - Capp Medical; CiberMed; Forty Seven

Honoraria - Janssen Oncology; Roche

Consulting or Advisory Role - Celgene; CiberMed; Foresight Diagnostics; Gilead Sciences; Roche/Genentech

Research Funding - Celgene

Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University.

Travel, Accommodations, Expenses - Gilead Sciences; Roche

Richard Eric  Davis

Research Funding - Karus Therapeutics (Inst)

Jason  Westin

Consulting or Advisory Role - Abbvie; ADC Therapeutics; Amgen; AstraZeneca; Bristol-Myers Squibb/Celgene/Juno; Curis; Forty Seven; Genentech/Roche; Iksuda Therapeutics; IMV; Janssen Scientific Affairs; Karyopharm Therapeutics; Kite/Gilead; Merck; Monte Rosa Therapeutics; MorphoSys; Novartis; Umoja Biopharma

Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Curis; Forty Seven; Genentech; Janssen; Kite/Gilead; MorphoSys; Novartis